Tetratherix Ltd. (TTX.AX)
Tetratherix Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Alexandria, NSW, AU. The stock last traded at $6.87, down 3.24% on the session, giving a market capitalisation of $364.4M. Its beta of 1.79 implies it has historically moved more than the broad market.
Established in 2015 and headquartered in Alexandria, Australia, Tetratherix Ltd. operates in the biomaterials and regenerative medicine sectors across both domestic and international markets. The company develops and supplies products using its proprietary Tetramatrix platform technology, with a focus on applications including bone regeneration, tissue spacing, and advanced tissue healing.
Tetratherix Ltd. is most often compared with the following Healthcare names: